AngioDynamics J.P. Morgan Conference: MedTech Growth Push, Cash-Flow Path, CEO Retirement Plan [Yahoo! Finance]
AngioDynamics, Inc. (ANGO)
Last angiodynamics, inc. earnings: 4/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.angiodynamics.com/investor-relations
Company Research
Source: Yahoo! Finance
Morgan to outline the company's multi-year portfolio transformation, highlight growth drivers across four key products, and discuss financial progress and near-term priorities. CEO Jim Clemmer and CFO Stephen Trowbridge also addressed Clemmer's planned retirement later this calendar year and how the company expects to manage leadership transition. Clemmer said AngioDynamics has worked over roughly the past five years to refresh its portfolio, moving from a legacy interventional radiology focus toward what management describes as a more science-driven “MedTech” portfolio aimed at larger, faster-growing addressable markets. He said the company completed three divestitures to exit businesses it viewed as slow-growth, undifferentiated, or more commodity-like. ? Inside D-Wave's Major Acquisition—What Changes for Investors As part of efforts to simplify its story, AngioDynamics reports in two operating segments: MedTech , described as the company's growth-focused future MedDevice
Show less
Read more
Impact Snapshot
Event Time:
ANGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANGO alerts
High impacting AngioDynamics, Inc. news events
Weekly update
A roundup of the hottest topics
ANGO
News
- The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic [Yahoo! Finance]Yahoo! Finance
- AngioDynamics (NASDAQ:ANGO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- ?????????????????????????????????????????2035????1,417???????????? [CNET News]CNET News
- ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves [Yahoo! Finance]Yahoo! Finance
- AngioDynamics (ANGO) Q1 2026 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
ANGO
Earnings
- 1/6/26 - Beat
ANGO
Sec Filings
- 1/14/26 - Form 8-K
- 1/8/26 - Form SCHEDULE
- 1/6/26 - Form 10-Q
- ANGO's page on the SEC website